New trial aims to find safer treatments for lung cancer patients with scarred lungs
NCT ID NCT07420439
First seen Feb 21, 2026 · Last updated May 06, 2026 · Updated 8 times
Summary
This study looks at the best way to treat advanced non-small cell lung cancer in people who also have interstitial lung disease (ILD), a condition that causes lung scarring. It will test a specific chemotherapy as a first treatment and an immunotherapy drug as a second treatment. The goal is to see how well these treatments control the cancer and how safe they are for this group of patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Angers - CHU
Angers, France
Contact Email: •••••@•••••
-
Annecy - CH
Pringy, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Besançon - CHU
Besançon, France
Contact Email: •••••@•••••
-
Bobigny - APHP - Hôpital Avicenne
Bobigny, France
Contact Email: •••••@•••••
-
Bordeaux - CHU
Pessac, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Boulogne - APHP Ambroise Paré
Boulogne-Billancourt, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Boulogne-Sur-Mer - CH
Boulogne-sur-Mer, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Brest - CHU
Brest, France
Contact
-
Caen - CHU Côte de Nacre
Caen, 14000, France
Contact
-
Clermont-Ferrand - CHU
Clermont-Ferrand, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Colmar - CH
Colmar, 68000, France
Contact
-
Créteil - CHI
Créteil, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dijon - CHU Bocage
Dijon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Grenoble - CHU
Grenoble, 38000, France
Contact
-
Lille - CHU
Lille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lyon - HCL
Lyon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Marseille - AP-HM Hôpital Nord
Marseille, France
Contact Email: •••••@•••••
-
Marseille - Institut Paoli Calmette
Marseille, France
Contact Email: •••••@•••••
-
Metz - Hôpital Robert Schuman
Metz, France
Contact Email: •••••@•••••
-
Montpellier - CHU
Montpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nantes - CHU Hôpital Laënnec
Nantes, France
Contact Email: •••••@•••••
-
Paris - APHP - Tenon
Paris, 75020, France
Contact Email: •••••@•••••
-
Paris - APHP Bichat
Paris, France
Contact Email: •••••@•••••
-
Paris - APHP Cochin
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Paris - APHP Pitié-salpêtrière
Paris, France
Contact Email: •••••@•••••
-
Paris - Saint Joseph
Paris, France
Contact Email: •••••@•••••
-
Rennes - CHU
Rennes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Strasbourg - NHC
Strasbourg, 63000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Suresnes - Foch
Suresnes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tours - CHU
Tours, France
Contact Email: •••••@•••••
-
Villefranche-Sur-Saône - Hôpital Nord-Ouest
Villefranche-sur-Saône, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.